EU regulator accepts Sanofi/Regeneron's Dupixent product for review

PARIS (Reuters) - The European Medicines Agency (EMA), the European Union's health regulator, has accepted for review the Dupixent product being developed by drugmakers Sanofi and Regeneron, the companies said on Thursday.